Effects of dietary glutamine on inflammatory mediator gene expressions in rats with streptozotocin-induced diabetes

Nutrition

Volumn 28, Issue 3, 2012, Pages 288-293

  Tsai, Pei Hsuan ^a   Yeh, Chui Li ^b   Liu, Jun Jen ^a   Chiu, Wan Chun ^a   Yeh, Sung Ling ^a  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b CHINESE CULTURE UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Glutamine; Receptor of advanced glycated endproducts; Reduced to oxidized glutathione ratio; Th17

Indexed keywords

C REACTIVE PROTEIN; CASEIN; FRUCTOSAMINE; GLUCOSE; GLUTAMINE; GLUTATHIONE; GLUTATHIONE DISULFIDE; INTERCELLULAR ADHESION MOLECULE 1;

ADVANCED GLYCATION ENDPRODUCT RECEPTOR GENE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DIET SUPPLEMENTATION; ERYTHROCYTE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; INTERLEUKIN 17A GENE; INTERLEUKIN 23 GENE; INTERLEUKIN 6 GENE; MALE; MONOCYTE CHEMOTACTIC PROTEIN 1 GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES; TH17 CELL; TRANSFORMING GROWTH FACTOR BETA1 GENE;

ANIMALS; BLOOD GLUCOSE; CHEMOKINE CCL2; DIABETES MELLITUS, EXPERIMENTAL; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; DOWN-REGULATION; FRUCTOSAMINE; GENE EXPRESSION; GLUTAMINE; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-6; LEUKOCYTES, MONONUCLEAR; MALE; NIACINAMIDE; RATS; RATS, WISTAR; RNA, MESSENGER; TH17 CELLS; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; RATTUS;

EID: 84856482229     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2011.06.003     Document Type: Article

References (38)

1. Department of Health, Taiwan. Top 10 leading causes of death in Taiwan; 2010. Available at: Accessed on June 15, 2011. http://www.doh.gov.tw.
2. Goh S.Y., Cooper M.E. Clinical review: the role of advanced glycation end products in progression and complications of diabetes. J Clin Endocrinol Metab 2008, 93:1143-1152.
3. Bierhaus A., Hofmann M.A., Ziegler R., Nawroth P.P. AGEs and their interaction with AGE-receptors in vascular disease and diabetes mellitus. I. The AGE concept. Cardiovasc Res 1998, 37:586-600.
4. Bierhaus A., Humpert P.M., Morcos M., Wendt T., Chavakis T., Arnold B., et al. Understanding RAGE, the receptor for advanced glycation end products. JMol Med 2005, 83:876-886.
5. Abbas A.K., Murphy K.M., Sher A. Functional diversity of helper T lymphocytes. Nature 1996, 383:787-793.
6. Bettelli E., Carrier Y., Gao W., Korn T., Strom T.B., Oukka M., et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006, 441:235-238.
7. Costa V.S., Mattana T.C., da Silva M.E. Unregulated IL-23/IL-17 immune response in autoimmune diseases. Diabet Res Clin Pract 2010, 88:222-226.
8. Park H., Li Z., Yang X.O., Chang S.H., Nurieva R., Wang Y.H., et al. A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005, 6:1133-1141.
9. Winer S., Paltser G., Chan Y., Tsui H., Engleman E., Winer D., et al. Obesity predisposes to Th17 bias. Eur J Immunol 2009, 39:2629-2635.
10. Wilmore D.W. The effect of glutamine supplementation in patients following elective surgery and accidental injury. J Nutr 2001, 131:2543S-2549S.
11. De-Souza D.A., Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005, 33:1125-1135.
12. Singleton K.D., Serkova N., Banerjee A., Meng X., Gamboni-Robertson F., Wischmeyer P.E. Glutamine attenuates endotoxin-induced lung metabolic dysfunction: potential role of enhanced heat shock protein 70. Nutrition 2005, 21:214-223.
13. Wischmeyer P.E., Jayakar D., Williams U., Singleton K.D., Riehm J., Bacha E.A., et al. Single dose of glutamine enhances myocardial tissue metabolism, glutathione content, and improves myocardial function after ischemia-reperfusion injury. JPEN 2003, 27:396-403.
14. Singleton K.D., Beckey V.E., Wischmeyer P.E. Glutamine prevents activation of NF-kappaB and stress kinase pathways, attenuates inflammatory cytokine release, and prevents acute respiratory distress syndrome (ARDS) following sepsis. Shock 2005, 24:583-589.
15. Herder C., Zierer A., Koenig W., Roden M., Meisinger C., Thorand B. Transforming growth factor-beta1 and incident type 2 diabetes: results from theMONICA/KORA case-cohort study, 1984-2002. Diabetes Care 2009, 32:1921-1923.
16. Andriankaja O.M., Barros S.P., Moss K., Panagakos F.S., DeVizio W., Beck J., et al. Levels of serum interleukin (IL)-6 and gingival crevicular fluid of IL-1beta and prostaglandin E(2) among non-smoking subjects with gingivitis and type 2 diabetes. J Periodontol 2009, 80:307-316.
17. Masiello P., Broca C., Gross R., Roye M., Manteghetti M., Hillaire-Buys D., et al. Experimental NIDDM: development of a new model in adult rats administered streptozotocin and nicotinamide. Diabetes 1998, 47:224-229.
18. Masiello P., Novelli M., Fierabracci V., Bergamini E. Protection by 3-aminobenzamide and nicotinamide against streptozotocin-induced beta-cell toxicity invivo and invitro. Res Commun Chem Pathol Pharmacol 1990, 69:17-32.
19. Kew S., Wells S.M., Yaqoob P., Wallace F.A., Miles E.A., Calder P.C. Dietary glutamine enhances murine T-lymphocyte responsiveness. J Nutr 1999, 129:1524-1531.
20. Wells S.M., Kew S., Yaqoob P., Wallace F.A., Calder P.C. Dietary glutamine enhances cytokine production by murine macrophages. Nutrition 1999, 15:881-884.
21. Chung H.F., Lees H., Gutman S.I. Effect of nitroblue tetrazolium concentration on the fructosamine assay for quantifying glycated protein. Clin Chem 1988, 34:2106-2111.
22. Tietze F. Enzymatic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem 1969, 27:502-522.
23. Ouyang W., Kolls J.K., Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 2008, 28:454-467.
24. Veldhoen M., Hocking R.J., Atkins C.J., Locksley R.M., Stockinger B. TGF-β in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006, 24:179-189.
25. McKenzie B.S., Kastelein R.A., Cua D.J. Understanding the IL-23-IL-17 immune pathway. Trends Immunol 2006, 27:17-23.
26. Opara E.C., Petro A., Tevrizian A., Feinglos M.N., Surwit R.S. L-glutamine supplementation of a high fat diet reduces body weight and attenuates hyperglycemia and hyperinsulinemia in C57BL/6J mice. J Nutr 1996, 126:273-279.
27. Tsai P.H., Liu J.J., Chiu W.C., Pai M.H., Yeh S.L. Effects of dietary glutamine on adhesion molecule expression and oxidative stress in mice with streptozotocin-induced type 1 diabetes. Clin Nutr 2011, 30:124-129.
28. Zhang L., Zalewski A., Liu Y., Mazurek T., Cowan S., Martin J.L., et al. Diabetes-induced oxidative stress and low-grade inflammation in porcine coronary arteries. Circulation 2003, 108:472-478.
29. Pradhan A.D., Manson J.E., Rifai N., Buring J.E., Ridker P.M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 2001, 286:327-334.
30. Glowinska B., Urban M., Peczynska J., Florys B. Soluble adhesion molecules (sICAM-1, sVCAM-1) and selectins (sE selectin, sP selectin, sL selectin) levels in children and adolescents with obesity, hypertension, and diabetes. Metabolism 2005, 54:1020-1026.
31. Springer T.A. Adhesion receptors of the immune system. Nature 1990, 346:425-434.
32. Henderson R.B., Lim L.H., Tessier P.A., Gavins F.N., Mathies M., Perretti M., et al. The use of lymphocyte function-associated antigen (LFA)-1-deficient mice to determine the role of LFA-1, Mac-1, and alpha4 integrin in the inflammatory response of neutrophils. J Exp Med 2001, 194:219-226.
33. Dragomir E., Simionescu M. Monocyte chemoattractant protein-1-a major contributor to the inflammatory process associated with diabetes. Arch Physiol Biochem 2006, 112:239-244.
34. Yan S.F., Ramasamy R., Schmidt A.M. Receptor for AGE (RAGE) and its ligands-cast into leading roles in diabetes and the inflammatory response. J Mol Med 2009, 87:235-247.
35. Roth E., Oehler R., Manhart N., Exner R., Wessner B., Strasser E., et al. Regulative potential of glutamine-relation to glutathione metabolism. Nutrition 2002, 18:217-221.
36. De Mattia G., Bravi M.C., Laurenti O., Cassone-Faldetta M., Armiento A., Ferri C., et al. Influence of reduced glutathione infusion on glucose metabolism in patients with non-insulin-dependent diabetes mellitus. Metabolism 1998, 47:993-997.
37. Welbourne T.C. Ammonia production and glutamine incorporation into glutathione in the functioning rat kidney. Can J Biochem 1979, 57:233-237.
38. Hong R.W., Rounds J.D., Helton W.S., Robinson M.K., Wilmore D.W. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg 1992, 215:114-119.